Fritextsökning
Innehållstyper
-
Extremely high sample throughput rates
Precision and reliability in automated liquid handling
-
Testar kapslar mot Alzheimer
En ny klinisk studie visar lovande effekter av kapslar som frisätter tillväxtfaktorn NGF.
-
Lundbeck divests companies
The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.
-
Biovitrum sells UK part
Biovitrum will soon spin-out a British subsidary
-
Bygger fosforåtervinning
En ny process för att återvinna fosfor i stor skala från förbränt avloppsslam har utvecklats av EasyMining och COWI.
-
KI dominerar i Wallenbergprogram
Alla de sju forskare som är årets Wallenberg Academy Fellows i medicin har en koppling till Karolinska Institutet.
-
Bought a tablet factory – and built his own empire
In 1995, Thomas Eldered was CEO of one of Pharmacia’s factories in the Stockholm area when the Swedish pharmaceutical giant, after a takeover, decided to move i...
-
Showroom for free
The latest equipment with trained staff. Sci Life Lab in Stockholm want to offer top conditions at the new imaging laboratory. But some vendors are skeptical to...
-
New CEO to Promedvi
Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.
-
Chatt inspirerade till bättre molnberäkningar
En grupp forskare har byggt en ny teknik för molnberäkningar. Istället för fråga-svar principen bygger programmet på omvänd kommunikation mellan server och dato...
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Swedish multi competent machine soon launched
The Swedish company Biosensor will launch new equipment able to detect twelve different narcotics and explosives simultaneously.
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Young, bright and committed to labtech
Ghazal Voghoui recently bought her first apartment and finally settled in Stockholm again. Last year, she finished her law studies and she is relieved to be bac...
-
Time to save for survival
The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.
-
Pharmacias baneman
Här är mannen som sålde ut den svenska läkemedelsindustrin. Åtminstone är det så många ser honom.
BREAKING